New role in asthma for old drug

The results of a study in mice by researchers from Erasmus University, The Netherlands, have indicated that an inhaled drug currently used to treat individuals with pulmonary arterial hypertension (raised blood pressure in the blood vessels in the lungs that leads to shortness of breath, dizziness, and fainting) might provide a new therapeutic to treat individuals with asthma.

Iloprost is a stable analog of the naturally occurring soluble factor PGI2. It is used to treat pulmonary arterial hypertension because it causes blood vessels to widen, thereby increasing blood flow and reducing blood pressure. However, recent studies have indicated that PGI2, and therefore iloprost, might also have anti-inflammatory properties. In a study that appears in the February issue of the Journal of Clinical Investigation, Bart Lambrecht and colleagues show that inhalation of iloprost inhibits the Th2 cell inflammatory response that causes disease in a mouse model of allergic asthma. Inhalation of iloprost inhibited this response in two ways. First, it prevented the immune cells in the lungs that activate the Th2 cell response (known as dendritic cells [DCs]) from leaving the lungs and going to the site at which they activate the allergic Th2 cell response. Second, it blocked the DCs becoming activated enough to stimulate an allergic Th2 cell response. This study therefore indicates that targeting DCs in the lungs can suppress allergic asthma in mice and might lead to studies determining whether such targeting by iloprost can provide a new treatment for individuals with asthma.


Contact: Karen Honey
Journal of Clinical Investigation

Page: 1

Related biology news :

1. Crystal structure enables tailoring of pharmaceuticals against asthma
2. New asthma gene could lead to new therapies
3. Book explores history, causes of allergy and asthma epidemic
4. Coarse particulate matter in air may harm hearts of asthma sufferers, UNC study finds
5. A new study links a stomach microbe to asthma prevention
6. Apple consumption during pregnancy reduces risk for childhood wheezing and asthma
7. Cincinnnati scientists pursue new target for asthma treatment
8. Potential new therapeutic target for asthma, allergies and cancer
9. Allergy/asthma and cystic fibrosis (CF) focus of awareness in May
10. A new view of asthmas cause
11. Women pregnant with girls experience more severe asthma symptoms

Post Your Comments:

(Date:10/16/2018)... ... October 16, 2018 , ... Nanomedical Diagnostics , ... new publication titled, “ Graphene-based Biosensor for On-Chip Detection of Bio-Orthogonally Labeled Proteins ... as a “new portable digital device for biosensing… that can be employed for ...
(Date:10/11/2018)... ... October 09, 2018 , ... ? ... market-ready technologies expedite their path to health system adoption and insurer reimbursement, ? ... across all major EHR applications, enabling them to focus on innovation not integration, ...
(Date:10/11/2018)... ... October 11, 2018 , ... ODSC Europe 2018 - ... 100% increase in attendance at the event from September 19-22. , As Europe’s ... intelligence sessions across 10 tracks and 4 days. Attendees were given key insights and ...
Breaking Biology News(10 mins):
(Date:10/2/2018)... (PRWEB) , ... October 02, 2018 , ... ... and Locus Bio-Energy Solutions™, LLC’s (Locus Bio-Energy) AssurEOR product line was chosen for ... Oil and Gulf Energy Information, honor leading innovations in upstream oil applications that ...
(Date:10/2/2018)... ... October 02, 2018 , ... ... this week that teams have initiated validation of standards and testing of procedures ... direction of Dr. Larry Kennedy, ACRES VP for Quality Management Systems and Chief ...
(Date:9/28/2018)... ... September 28, 2018 , ... ... to increase the availability of the GlycoMark test, the only FDA-cleared blood test ... the partnership, PMLS will promote and offer the GlycoMark test to its network ...
(Date:9/27/2018)... ... 26, 2018 , ... NDA Partners Chairman Carl Peck, ... and in vitro diagnostic device expert with more than 28 years of experience ... as an Expert Consultant. Her experience includes leadership roles in regulatory strategy, quality ...
Breaking Biology Technology:
Cached News: